Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INSMED Inc Director's Dealing 2012

Jun 5, 2012

30150_dirs_2012-06-05_b0d808ac-0e18-48cb-bd62-d2793c9d1788.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED INC (INSM)
CIK: 0001104506
Period of Report: 2012-06-04

Reporting Person: SHAROKY MELVIN MD (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-06-04 Common Stock P 20000 Acquired 127837 Direct

Footnotes

F1: Purchase price ranged from $2.98 to $3.03. $3.0214 was the average price paid for the 20,000 shares purchased.